|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/47 | |
| C07K 16/30 | |||
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2392593 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11002015.3 |
| Date of filing the European patent application | 2005-05-18 | |
| (97) | Date of publication of the European application | 2011-12-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 102004024617 | 2004-05-18 | DE |
| (72) |
Türeci, Özlem, DE
Sahin, Ugur, DE
Koslowski, Michael, DE
Fritz, Stefan, DE
Geppert, Harald-Gerhard, DE
|
| (73) |
Ganymed Pharmaceuticals GmbH,
An der Goldgrube 12, 55131 Mainz,
DE
|
| (54) | DIFFERENTIELL IN TUMOREN EXPRIMIERTE GENPRODUKTE UND DEREN VERWENDUNG |
| DIFFERENTIAL IN TUMOUR GENE PRODUCTS AND USE OF SAME |